Argatroban Market 2027 By Type, Application, and Geography | The Insight Partners

Argatroban Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Argatroban Powder, Argatroban Injection) ; Application (Heparin-induced thrombocytopenia (HIT), Percutaneous Coronary Intervention, Cerebral arterial thrombosis) and Geography

Report Code: TIPRE00008657 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Argatroban is an odorless, white, crystalline powder which is freely soluble in glacial acetic acid. Argatroban, an anticoagulant is a direct thrombin inhibitor and is approved by the food and drug administration for treatment of prophylaxis or thrombosis in patients with heparin-induced thrombocytopenia (HIT). Argatroban Injection is indicated to adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI).

MARKET DYNAMICS

Argatroban market is anticipated to grow in the forecast period owing to increasing prevalence of heparin-related complications, and rise in number of cerebral arterial thrombosis. Moreover, rising allergies associated with argatroban by the market players is likely to hamper market growth during the forecast period.

MARKET SCOPE

The "Global Argatroban Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Argatroban market with detailed market segmentation by type, application and geography. The global Argatroban market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Argatroban market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global argatroban market is segmented on the basis of product and end user. Based on type, the market is segmented as argatroban powder, and argatroban injection. On the basis of application the market is segmented into heparin-induced thrombocytopenia (HIT), percutaneous coronary intervention, and cerebral arterial thrombosis.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Argatroban market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Argatroban market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Argatroban market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Argatroban market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Argatroban market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Argatroban market are anticipated to lucrative growth opportunities in the future with the rising demand for Argatroban market in the global market. Below mentioned is the list of few companies engaged in the Argatroban market.

The report also includes the profiles of key Argatroban market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Pfizer, Inc
- SANDOZ
- GlaxoSmithKline Plc
- Fresenius-Kabi
- Eagle Pharmaceuticals, Inc
- Mitsubishi Tanabe Pharma
- Teva Pharmaceutical Industries Ltd
- WEST-WARD,INC
- Midas Pharma GmBH
- Aurobindo Pharma Limited

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Argatroban Market - By Type
1.3.2 Argatroban Market - By Application
1.3.3 Argatroban Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ARGATROBAN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ARGATROBAN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ARGATROBAN MARKET - GLOBAL MARKET ANALYSIS
6.1. ARGATROBAN - GLOBAL MARKET OVERVIEW
6.2. ARGATROBAN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ARGATROBAN MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ARGATROBAN POWDER
7.3.1. Overview
7.3.2. Argatroban Powder Market Forecast and Analysis
7.4. ARGATROBAN INJECTION
7.4.1. Overview
7.4.2. Argatroban Injection Market Forecast and Analysis
8. ARGATROBAN MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
8.3.1. Overview
8.3.2. Heparin-induced thrombocytopenia (HIT) Market Forecast and Analysis
8.4. PERCUTANEOUS CORONARY INTERVENTION
8.4.1. Overview
8.4.2. Percutaneous Coronary Intervention Market Forecast and Analysis
8.5. CEREBRAL ARTERIAL THROMBOSIS
8.5.1. Overview
8.5.2. Cerebral arterial thrombosis Market Forecast and Analysis
9. ARGATROBAN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Argatroban Market Overview
9.1.2 North America Argatroban Market Forecasts and Analysis
9.1.3 North America Argatroban Market Forecasts and Analysis - By Type
9.1.4 North America Argatroban Market Forecasts and Analysis - By Application
9.1.5 North America Argatroban Market Forecasts and Analysis - By Countries
9.1.5.1 United States Argatroban Market
9.1.5.1.1 United States Argatroban Market by Type
9.1.5.1.2 United States Argatroban Market by Application
9.1.5.2 Canada Argatroban Market
9.1.5.2.1 Canada Argatroban Market by Type
9.1.5.2.2 Canada Argatroban Market by Application
9.1.5.3 Mexico Argatroban Market
9.1.5.3.1 Mexico Argatroban Market by Type
9.1.5.3.2 Mexico Argatroban Market by Application
9.2. EUROPE
9.2.1 Europe Argatroban Market Overview
9.2.2 Europe Argatroban Market Forecasts and Analysis
9.2.3 Europe Argatroban Market Forecasts and Analysis - By Type
9.2.4 Europe Argatroban Market Forecasts and Analysis - By Application
9.2.5 Europe Argatroban Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Argatroban Market
9.2.5.1.1 Germany Argatroban Market by Type
9.2.5.1.2 Germany Argatroban Market by Application
9.2.5.2 France Argatroban Market
9.2.5.2.1 France Argatroban Market by Type
9.2.5.2.2 France Argatroban Market by Application
9.2.5.3 Italy Argatroban Market
9.2.5.3.1 Italy Argatroban Market by Type
9.2.5.3.2 Italy Argatroban Market by Application
9.2.5.4 Spain Argatroban Market
9.2.5.4.1 Spain Argatroban Market by Type
9.2.5.4.2 Spain Argatroban Market by Application
9.2.5.5 United Kingdom Argatroban Market
9.2.5.5.1 United Kingdom Argatroban Market by Type
9.2.5.5.2 United Kingdom Argatroban Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Argatroban Market Overview
9.3.2 Asia-Pacific Argatroban Market Forecasts and Analysis
9.3.3 Asia-Pacific Argatroban Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Argatroban Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Argatroban Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Argatroban Market
9.3.5.1.1 Australia Argatroban Market by Type
9.3.5.1.2 Australia Argatroban Market by Application
9.3.5.2 China Argatroban Market
9.3.5.2.1 China Argatroban Market by Type
9.3.5.2.2 China Argatroban Market by Application
9.3.5.3 India Argatroban Market
9.3.5.3.1 India Argatroban Market by Type
9.3.5.3.2 India Argatroban Market by Application
9.3.5.4 Japan Argatroban Market
9.3.5.4.1 Japan Argatroban Market by Type
9.3.5.4.2 Japan Argatroban Market by Application
9.3.5.5 South Korea Argatroban Market
9.3.5.5.1 South Korea Argatroban Market by Type
9.3.5.5.2 South Korea Argatroban Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Argatroban Market Overview
9.4.2 Middle East and Africa Argatroban Market Forecasts and Analysis
9.4.3 Middle East and Africa Argatroban Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Argatroban Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Argatroban Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Argatroban Market
9.4.5.1.1 South Africa Argatroban Market by Type
9.4.5.1.2 South Africa Argatroban Market by Application
9.4.5.2 Saudi Arabia Argatroban Market
9.4.5.2.1 Saudi Arabia Argatroban Market by Type
9.4.5.2.2 Saudi Arabia Argatroban Market by Application
9.4.5.3 U.A.E Argatroban Market
9.4.5.3.1 U.A.E Argatroban Market by Type
9.4.5.3.2 U.A.E Argatroban Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Argatroban Market Overview
9.5.2 South and Central America Argatroban Market Forecasts and Analysis
9.5.3 South and Central America Argatroban Market Forecasts and Analysis - By Type
9.5.4 South and Central America Argatroban Market Forecasts and Analysis - By Application
9.5.5 South and Central America Argatroban Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Argatroban Market
9.5.5.1.1 Brazil Argatroban Market by Type
9.5.5.1.2 Brazil Argatroban Market by Application
9.5.5.2 Argentina Argatroban Market
9.5.5.2.1 Argentina Argatroban Market by Type
9.5.5.2.2 Argentina Argatroban Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ARGATROBAN MARKET, KEY COMPANY PROFILES
11.1. PFIZER INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANDOZ
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLAXOSMITHKLINE PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. FRESENIUS KABI AG
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. EAGLE PHARMACEUTICALS INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MITSUBISHI TANABE PHARMA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. WEST-WARD,INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MIDAS PHARMA GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. AUROBINDO PHARMA LIMITED
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer, Inc
2. SANDOZ
3. GlaxoSmithKline Plc
4. Fresenius-Kabi
5. Eagle Pharmaceuticals, Inc
6. Mitsubishi Tanabe Pharma
7. Teva Pharmaceutical Industries Ltd
8. WEST-WARD,INC
9. Midas Pharma GmBH
10. Aurobindo Pharma Limited
TIPRE00008657
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking